Long-Term Efficacy and Safety of Guselkumab for Moderate to Severe Psoriasis: A 3-Year Real-Life Retrospective Study.

Matteo MegnaLuca PotestioGabriella FabbrociniRuggiero Angelo

Published in: Psoriasis (Auckland, N.Z.) (2022)

Our experience confirmed the efficacy and safety of guselkumab in daily clinical practice up to 3 years, suggesting this drug as an effective treatment option in psoriasis long-term management.

Keyphrases

clinical practice
high intensity
emergency department
drug induced
combination therapy
electronic health record
replacement therapy